A student-led monthly journal written by the SLHS Cancer Research Society officer team, dedicated to transforming how future generations understand, communicate, and act on the fight against cancer. Founded in 2025 on three pillars: Education, Research, and Impact
Hot off the press.
OncoLegacy Journal, Volume I, Issue XI.pdfPaclitaxel
Dive into the discovery of the modern drug, Paclitaxel, and how its mechanism drives precise patient care and higher cure rates. A data-driven look at specialized treatment from another perspective.
Explore past publications.
Every issue captures a unique dimension of oncology — from molecular science to the human experience. Each month, we publish a major journal with bi-weekly issues exploring a specific lens on a problem in oncology.
National OncoLegacy Foundation, Volume I, Issue I.pdfHow cancer begins, grows, and spreads — a foundational look at the biology and why early understanding matters.
Jason Fang, Editor-in-Chief · July 2025
National OncoLegacy Foundation, Volume I, Issue II.pdfPrevention, Detection, Treatment
Detection, prevention, and treatment strategies — from early screening to immunotherapy, and the power of early action.
Jason Fang, Editor-in-Chief · Aug2025
National OncoLegacy Foundation, Volume I, Issue III.pdfCancer Mortality
A data-driven deep dive into cancer death rates worldwide, revealing progress made and the disparities that still exist.
Jason Fang, Editor-in-Chief · Sep 2025
National OncoLegacy Journal, Volume I, Issue IV.pdfThe economic burden of cancer treatment, and how the cost of survival shapes both medical care and the patient's well-being.
Jason Fang, Editor-in-Chief · Oct 2025
National OncoLegacy Journal, Volume I, Issue V.pdfJason Fang, Editor-in-Chief · Nov 2025
National OncoLegacy Foundation, Volume I, Issue VI.pdfHow immunotherapies harness the body's own defenses to fight cancer, highlighting key treatments and measurable impacts on survival.
Jason Fang, Editor-in-Chief · Dec 2025
National OncoLegacy Foundation, Volume I, Issue VII.pdfThe biological and clinical perspectives of how advanced cancers transform into treatment-resistant, aggressive variant tumors.
Jason Fang, Editor-in-Chief · Jan 2026
National OncoLegacy Foundation, Volume I, Issue VIII.pdfExplores the rapidly advancing field of computational oncology, how it's transforming drug development, and a current student research case study.
Jason Fang, Editor-in-Chief · Feb 2026
National OncoLegacy Foundation, Volume I, Issue IX.pdfDives into the specialized field of surgical oncology and how it's transforming patient care and increasing cure rates across various cancers.
Jason Fang, Editor-in-Chief · March 2026
OncoLegacy Journal, Volume I, Issue X.pdfDives into radiation oncology — how its physics and artificial intelligence drive precise patient care and higher cure rates across cancers. A data-driven look at treatment from another perspective.
Jason Fang, Editor-in-Chief · April 2026
OncoLegacy Journal, Volume I, Issue XI.pdfDive into the discovery of the modern drug, Paclitaxel, and how its mechanism drives precise patient care and higher cure rates. A data-driven look at specialized treatment from another perspective.
Jason Fang, Editor-in-Chief · May 2026
Currently in Progress
Prisha Sharma, Editor · June 2026
